Trevor Martin, CEO and Co-Founder of Mammoth Biosciences.
Trevor is focused on creating the world’s first CRISPR-based platform for disease detection, taking impactful CRISPR technology out of the lab and bringing it into the hands of doctors and consumers. Prior to co-founding Mammoth, Trevor completed his PhD in Biology at Stanford University, where he worked at the intersection of statistics and genetics. In addition to having co-taught a course in Statistics at Stanford, Trevor has penned educational guides for university courses across the globe. His work has been featured in outlets like FiveThirtyEight and The Atlantic.